
9. Late and Long-Term Symptoms & Management
•Toxicities
•Cardiotoxicity
•Pulmonary
•Gastrointestinal
•Genitourinary
•Endocrine
•Cutaneous
•Immune/lymphatic system
•Nervous system
•Musculoskeletal
•Psychological effects
•Summary
Haleigh Mistry (Moderator)
MS, PA-C
University of Texas MD Anderson Cancer Center
Haleigh is a Physician Assistant at University of Texas MD Anderson Cancer Center in Houston, Texas. She has over 11 years of clinical experience, specializing in lymphoma/myeloma, cancer survivorship, and adolescent and young adult (AYA) oncology. She enjoys precepting students and serves on several committees at MDACC.
In her free time, she enjoys spending time with her kids and family, gardening, and fostering animals.
Haleigh Mistry has the following relevant financial disclosures:
•Advisory Board: GenMab, ADC Therapeutics, and AbbVie
•Provide the most common late effect/toxicities from cancer therapy.
•Discuss associated symptoms/presentation of these late effects.
•Discuss basic management of these toxicities.
Key:




